117th Congress · HOUSE CONCURRENT RESOLUTIONBILL

H.Con.Res. 42Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Health
Introduced Jul 21, 2021
Last action Jul 22, 2021
Pipeline · Bill → Law
Step 1
Introduced
Jul 21, 2021
Step 2
Referred
Jul 22, 2021
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 1 sectionsIntroduced in House
Timeline · 3 actions
Jul 22, 2021
Referred to the Subcommittee on Health.
Jul 21, 2021
Introduced in House
Jul 21, 2021
Referred to the House Committee on Energy and Commerce.